Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06294587 · ClinicalTrials.gov registry record · NA
Evaluation of Free Gingival Graft Timing
A NA study of Ridge Augmentation and Alveolar Mucosa, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06294587: Recruiting NA study of Ridge Augmentation and Alveolar Mucosa, sponsored by University of Alabama at Birmingham.
NCT06294587 is a NA study of Ridge Augmentation and Alveolar Mucosa that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06294587, a NA study of Ridge Augmentation and Alveolar Mucosa, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial aims to compare and evaluate the clinical outcomes between two distinct treatment sequences: free gingival graft surgery preceding guided bone regeneration and guided bone regeneration followed by free gingival graft.
Primary Outcome
The volumetric outcomes of interest will be volume change in mm3 (Vol) and the mean distance between the surface/mean thickness of the reconstructed volume in mm.
Conditions Studied
Interventions
- PROCEDURE FGG Before GBR
- PROCEDURE FGG after GBR
Study Locations (1)
Alabama
- Unversity of Alabama at Birmingham, School of Dentistry - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-08-12 |
| Est. Completion | 2027-08-30 |
| Phase | NA |
What NCT06294587 shows while recruiting
NCT06294587 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Ridge Augmentation appearing as the primary indexed condition, and to 2 interventions - of which FGG Before GBR is the first listed.
NCT06294587 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06294587 about?
NCT06294587 is a clinical study titled "Evaluation of Free Gingival Graft Timing". This clinical trial aims to compare and evaluate the clinical outcomes between two distinct treatment sequences: free gingival graft surgery preceding guided bone regeneration and guided bone regeneration followed by free gingival graft.
What is the current status of trial NCT06294587?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-12. Estimated completion is 2027-08-30.
What conditions does trial NCT06294587 study?
This clinical trial studies the following conditions: Ridge Augmentation, Alveolar Mucosa.
What interventions are being tested in trial NCT06294587?
The interventions under investigation include: FGG Before GBR (PROCEDURE), FGG after GBR (PROCEDURE).
Who is sponsoring clinical trial NCT06294587?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06294587 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ridge Augmentation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06294587's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI